Jinyu Bio-Technology Co Ltd (600201) - Net Assets

Latest as of June 2026: CN¥5.53 Billion CNY ≈ $808.63 Million USD

Based on the latest financial reports, Jinyu Bio-Technology Co Ltd (600201) has net assets worth CN¥5.53 Billion CNY (≈ $808.63 Million USD) as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥6.62 Billion ≈ $968.24 Million USD) and total liabilities (CN¥1.09 Billion ≈ $159.62 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check how strategically is Jinyu Bio-Technology Co Ltd's equity deployed to assess the company's strategic physical and investment asset allocation.

Key Net Assets Metrics

Metric	Value
Current Net Assets	CN¥5.53 Billion
% of Total Assets	83.51%
Annual Growth Rate	15.23%
5-Year Change	-0.17%
10-Year Change	47.92%
Growth Volatility	54.65

Jinyu Bio-Technology Co Ltd - Net Assets Trend (1995–2025)

This chart illustrates how Jinyu Bio-Technology Co Ltd's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see 600201 company net worth.

Annual Net Assets for Jinyu Bio-Technology Co Ltd (1995–2025)

The table below shows the annual net assets of Jinyu Bio-Technology Co Ltd from 1995 to 2025. Also explore Jinyu Bio-Technology Co Ltd net asset momentum to track the company's year-over-year net asset growth rate.

Year	Net Assets	Change
2025-12-31	CN¥5.55 Billion ≈ $812.27 Million	+2.50%
2024-12-31	CN¥5.42 Billion ≈ $792.44 Million	-4.24%
2023-12-31	CN¥5.65 Billion ≈ $827.50 Million	+5.71%
2022-12-31	CN¥5.35 Billion ≈ $782.82 Million	-3.79%
2021-12-31	CN¥5.56 Billion ≈ $813.64 Million	+5.65%
2020-12-31	CN¥5.26 Billion ≈ $770.13 Million	+8.09%
2019-12-31	CN¥4.87 Billion ≈ $712.50 Million	-6.77%
2018-12-31	CN¥5.22 Billion ≈ $764.23 Million	+16.63%
2017-12-31	CN¥4.48 Billion ≈ $655.26 Million	+19.33%
2016-12-31	CN¥3.75 Billion ≈ $549.13 Million	+81.41%
2015-12-31	CN¥2.07 Billion ≈ $302.70 Million	+26.87%
2014-12-31	CN¥1.63 Billion ≈ $238.59 Million	+27.20%
2013-12-31	CN¥1.28 Billion ≈ $187.57 Million	+18.95%
2012-12-31	CN¥1.08 Billion ≈ $157.69 Million	+8.73%
2011-12-31	CN¥991.13 Million ≈ $145.03 Million	+17.41%
2010-12-31	CN¥844.15 Million ≈ $123.53 Million	+12.41%
2009-12-31	CN¥750.98 Million ≈ $109.89 Million	+3.80%
2008-12-31	CN¥723.47 Million ≈ $105.87 Million	+2.11%
2007-12-31	CN¥708.54 Million ≈ $103.68 Million	+16.96%
2006-12-31	CN¥605.80 Million ≈ $88.65 Million	+4.96%
2005-12-31	CN¥577.16 Million ≈ $84.46 Million	-5.23%
2004-12-31	CN¥609.02 Million ≈ $89.12 Million	+6.11%
2003-12-31	CN¥573.94 Million ≈ $83.99 Million	+8.33%
2002-12-31	CN¥529.82 Million ≈ $77.53 Million	+2.44%
2001-12-31	CN¥517.19 Million ≈ $75.68 Million	+50.00%
2000-12-31	CN¥344.80 Million ≈ $50.45 Million	+3.05%
1999-12-31	CN¥334.58 Million ≈ $48.96 Million	+0.46%
1998-12-31	CN¥333.06 Million ≈ $48.74 Million	+300.33%
1997-12-31	CN¥83.20 Million ≈ $12.17 Million	+4.74%
1996-12-31	CN¥79.43 Million ≈ $11.62 Million	+0.74%
1995-12-31	CN¥78.85 Million ≈ $11.54 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Jinyu Bio-Technology Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 110411.8% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2025)

Component	Amount	Percentage
Retained Earnings	CN¥3.24 Billion	60.32%
Other Components	CN¥2.13 Billion	39.68%
Total Equity	CN¥5.37 Billion	100.00%

Jinyu Bio-Technology Co Ltd Competitors by Market Cap

The table below lists competitors of Jinyu Bio-Technology Co Ltd ranked by their market capitalization.

Company	Market Cap
A.F.P. Provida SN:PROVIDA	$1.89 Billion
Galapagos NV ADR NASDAQ:GLPG	$1.89 Billion
Eastern Communications Co Ltd A SHG:600776	$1.89 Billion
Luenmei Quantum Co Ltd SHG:600167	$1.89 Billion
Target Hospitality Corp NASDAQ:TH	$1.89 Billion
L&F Co. Ltd KQ:066970	$1.88 Billion
Hubei Yihua Chemical Industry Co Ltd SHE:000422	$1.88 Billion
Sichuan Expressway Co Ltd SHG:601107	$1.88 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Jinyu Bio-Technology Co Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 5,314,336,328 to 5,368,046,823, a change of 53,710,495 (1.0%).
Net income of 100,111,638 contributed positively to equity growth.
Dividend payments of 33,316,234 reduced retained earnings.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	CN¥100.11 Million	+1.86%
Dividends Paid	CN¥33.32 Million	-0.62%
Other Changes	CN¥-13.08 Million	-0.24%
Total Change	CN¥-	1.01%

Book Value vs Market Value Analysis

This analysis compares Jinyu Bio-Technology Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 2.43x
The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
The price-to-book ratio has decreased from 129.50x to 2.43x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
1995-12-31	CN¥0.09	CN¥11.73	x
1996-12-31	CN¥0.09	CN¥11.73	x
1997-12-31	CN¥0.10	CN¥11.73	x
1998-12-31	CN¥0.38	CN¥11.73	x
1999-12-31	CN¥0.38	CN¥11.73	x
2000-12-31	CN¥0.39	CN¥11.73	x
2001-12-31	CN¥0.59	CN¥11.73	x
2002-12-31	CN¥0.60	CN¥11.73	x
2003-12-31	CN¥0.65	CN¥11.73	x
2004-12-31	CN¥0.70	CN¥11.73	x
2005-12-31	CN¥0.66	CN¥11.73	x
2006-12-31	CN¥0.61	CN¥11.73	x
2007-12-31	CN¥0.68	CN¥11.73	x
2008-12-31	CN¥0.71	CN¥11.73	x
2009-12-31	CN¥0.74	CN¥11.73	x
2010-12-31	CN¥0.82	CN¥11.73	x
2011-12-31	CN¥0.96	CN¥11.73	x
2012-12-31	CN¥1.04	CN¥11.73	x
2013-12-31	CN¥1.25	CN¥11.73	x
2014-12-31	CN¥1.60	CN¥11.73	x
2015-12-31	CN¥2.01	CN¥11.73	x
2016-12-31	CN¥3.54	CN¥11.73	x
2017-12-31	CN¥3.90	CN¥11.73	x
2018-12-31	CN¥4.40	CN¥11.73	x
2019-12-31	CN¥4.20	CN¥11.73	x
2020-12-31	CN¥4.45	CN¥11.73	x
2021-12-31	CN¥4.69	CN¥11.73	x
2022-12-31	CN¥4.66	CN¥11.73	x
2023-12-31	CN¥4.94	CN¥11.73	x
2024-12-31	CN¥4.83	CN¥11.73	x
2025-12-31	CN¥4.83	CN¥11.73	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Jinyu Bio-Technology Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 1.86%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 7.17%
• Asset Turnover: 0.21x
• Equity Multiplier: 1.23x
Recent ROE (1.86%) is below the historical average (11.69%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
1995	24.89%	20.34%	0.45x	2.70x	CN¥11.74 Million
1996	27.28%	22.19%	0.47x	2.64x	CN¥13.72 Million
1997	29.86%	16.42%	0.74x	2.45x	CN¥16.53 Million
1998	6.46%	13.86%	0.35x	1.32x	CN¥-11.80 Million
1999	8.87%	17.80%	0.35x	1.43x	CN¥-3.77 Million
2000	5.19%	9.07%	0.34x	1.66x	CN¥-16.52 Million
2001	2.76%	6.83%	0.27x	1.48x	CN¥-37.37 Million
2002	7.68%	13.70%	0.36x	1.55x	CN¥-12.16 Million
2003	7.78%	13.22%	0.35x	1.69x	CN¥-12.58 Million
2004	7.29%	9.47%	0.44x	1.74x	CN¥-16.46 Million
2005	2.14%	2.22%	0.53x	1.82x	CN¥-45.23 Million
2006	6.33%	6.81%	0.60x	1.56x	CN¥-22.16 Million
2007	13.32%	13.23%	0.54x	1.86x	CN¥23.14 Million
2008	10.11%	8.86%	0.66x	1.74x	CN¥820.76K
2009	8.85%	9.84%	0.48x	1.86x	CN¥-8.62 Million
2010	13.74%	17.18%	0.42x	1.90x	CN¥31.38 Million
2011	15.13%	25.94%	0.33x	1.75x	CN¥50.69 Million
2012	12.12%	23.44%	0.30x	1.75x	CN¥22.85 Million
2013	19.57%	37.37%	0.39x	1.34x	CN¥122.70 Million
2014	24.76%	38.04%	0.51x	1.29x	CN¥241.06 Million
2015	23.19%	38.49%	0.49x	1.23x	CN¥272.85 Million
2016	17.19%	42.49%	0.35x	1.16x	CN¥269.60 Million
2017	19.46%	45.77%	0.33x	1.27x	CN¥423.03 Million
2018	15.00%	39.78%	0.30x	1.25x	CN¥251.32 Million
2019	4.76%	19.62%	0.20x	1.20x	CN¥-243.69 Million
2020	8.15%	25.68%	0.25x	1.26x	CN¥-91.97 Million
2021	7.25%	21.52%	0.27x	1.25x	CN¥-144.94 Million
2022	4.15%	13.78%	0.24x	1.26x	CN¥-296.56 Million
2023	5.28%	17.75%	0.23x	1.28x	CN¥-253.06 Million
2024	2.05%	8.68%	0.19x	1.27x	CN¥-422.45 Million
2025	1.86%	7.17%	0.21x	1.23x	CN¥-436.69 Million

Industry Comparison

This section compares Jinyu Bio-Technology Co Ltd's net assets metrics with peer companies in the Biotechnology industry.

Industry Context

Industry: Biotechnology
Average net assets among peers: $923,055,083
Average return on equity (ROE) among peers: 12.41%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Jinyu Bio-Technology Co Ltd (600201)	CN¥5.53 Billion	24.89%	0.20x	$1.89 Billion
Shenzhen CAU Technology Co Ltd (000004)	$85.02 Million	9.34%	2.79x	$9.88 Million
Pacific Shuanglin Bio pharmacy Co Ltd (000403)	$64.35 Million	12.98%	2.10x	$1.37 Billion
Nanhua Bio Medicine Co Ltd (000504)	$-14.51 Million	0.00%	0.00x	$483.41 Million
Jiangsu Sihuan Bioengineering Co Ltd (000518)	$915.76 Million	-0.65%	0.06x	$575.51 Million
Chengzhi Shareholding Co Ltd (000990)	$160.52 Million	17.55%	0.67x	$1.61 Billion
Hualan Biological EngineeringInc (002007)	$5.77 Billion	19.74%	0.12x	$3.46 Billion
Da An Gene Co Ltd of Sun Yat-Sen University (002030)	$269.70 Million	9.75%	0.10x	$1.10 Billion
Shanghai RAAS Blood Products Co Ltd Class A (002252)	$763.33 Million	17.77%	0.08x	$4.76 Billion
Baolingbao Biology Co Ltd (002286)	$817.45 Million	8.40%	0.36x	$428.14 Million
Tibet Cheezheng Tibetan Medicine Co Ltd (002287)	$396.33 Million	29.23%	0.30x	$1.62 Billion

About Jinyu Bio-Technology Co Ltd

SHG:600201 China Biotechnology

Market Cap

$1.89 Billion

CN¥12.90 Billion CNY

Market Cap Rank

#6420 Global

#1281 in China

Share Price

CN¥11.73

Change (1 day)

+0.43%

52-Week Range

CN¥8.71 - CN¥18.78

All Time High

CN¥30.02